ArticleOncoimmunology2021

An immunogenic first-in-human immune modulatory vaccine with PD-L1 and PD-L2 peptides is feasible and shows early signs of efficacy in follicular lymphoma.

Uffe Klausen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.